Deerfield Private Design Fund IV, L.P.
CIK 1680307 · last filed 2025-11-24
Deerfield Private Design Fund IV, L.P. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider sold $70.9M of NUVL on Nov 24, 2025. Across all open-market trades the lifetime net is −$74.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $85.2M across reported positions. The firm reports its address in New York, NY. 48 SEC filings were submitted jointly with DEERFIELD MANAGEMENT COMPANY, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NUVL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10017
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Nuvalent, Inc. (NUVL) Delisted | Director | 8,299,225 | $123.96 | $1.03B | -$70.87M | 1 | 2025-11-24 |
| AHCO | 10%+ Owner | 11,528,863 | $7.39 | $85.20M | -$3.82M | 1 | 2024-03-12 |
| AdaptHealth Corp. (VTL) Delisted | Director | 174,188 | — | — | $0 | 1 | 2018-02-23 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-24 | Nuvalent, Inc. (NUVL) Delisted | Sell (S) | −742,574 | -$70.87M | EDGAR |
| 2024-10-22 | Nuvalent, Inc. (NUVL) Delisted | Notice (144) | −1,000,000 | -$101.16M | EDGAR |
| 2024-03-12 | AHCO | Sell (S) | −350,000 | -$3.82M | EDGAR |
| 2018-02-23 | AdaptHealth Corp. (VTL) Delisted | Buy (P) | +2,500,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.